Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant's portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma's ...

The centerpiece of the acquisition is Ohtuvayre, a treatment for chronic obstructive pulmonary disease that secured U.S. approval last year. The drug’s commercial launch has exceeded Wall Street ...

By quantizing weights with different precision for different parts of a network, mixed-precision quantization promises to reduce the hardware cost and improve the speed of deep neural network (DNN) ...

Merck's Winrevair reduced clinical worsening in PAH patients in the Phase 3 HYPERION trial, building on prior positive study outcomes.

Merck said that a phase-three study of its pulmonary arterial hypertension treatment met its primary endpoints. On Monday, the pharmaceutical company said it has received positive topline results ...

The Merck Foundation hosted its 7th Merck Foundation First Ladies Initiative (MFFLI) Summit in Dubai, focusing on enhancing healthcare in Africa and Asia. Esteemed guests included First Ladies from 14 ...

MSD and Daiichi Sankyo have announced first subject dosing in the randomised IDeate-Prostate01 Phase III trial of ifinatamab deruxtecan (I-DXd) against docetaxel in individuals with metastatic ...

Abbott and MSD Pharmaceuticals on Wednesday announced a strategic distribution partnership to expand access to MSD’s oral anti-diabetic portfolio in India, including sitagliptin and its fixed ...

Editor’s note: This story was updated at 8:47 a.m. June 19, 2025, to note that Merck Manuals – a separate entity from Merck – launched the new tool.

Earlier, the Chairman of the Merck Foundation Board of Trustees, Prof. Dr. Frank Stangenberg-Haverkamp, applauded the First Ladies’ commitment to healthcare and social development.

Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert witnesses for plaintiffs suing Merck & Co. over some of the drug company ...

RAHWAY, N.J., June 12, 2025--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...